URGN — UroGen Pharma Ltd. stock price, charts and financials

QT71UroGen Pharma Ltd.

UroGen Pharma Ltd. (NASDAQ: URGN) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
39.92
+1.33+3.45%
OverviewShort InterestFilings
URGNQT71UroGen Pharma Ltd.·NASDAQ
39.92+3.45%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 10, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 09, 20264Statement of changes in beneficial ownership
Jun 02, 20268-KCurrent report
May 27, 2026ARSAnnual report to shareholders
May 27, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 11, 20264Statement of changes in beneficial ownership
May 06, 20268-KCurrent report
May 06, 202610-QQuarterly report
Apr 30, 2026DEF 14ADefinitive proxy statement
Apr 27, 2026SC 13GBeneficial ownership statement (passive)
Apr 17, 2026PRE 14APreliminary proxy statement
Mar 02, 20268-KCurrent report
Mar 02, 202610-KAnnual report
Mar 02, 20268-KCurrent report
Feb 27, 20264Statement of changes in beneficial ownership
#1 / 25 of 296
Page
▼
/ 12